129 related articles for article (PubMed ID: 8566119)
1. Effect of rolipram in a murine model of acute inflammation: comparison with the corticoid dexamethasone.
Klemm P; Harris HJ; Perretti M
Eur J Pharmacol; 1995 Jul; 281(1):69-74. PubMed ID: 8566119
[TBL] [Abstract][Full Text] [Related]
2. The effects of antiinflammatory and antiallergic drugs on cytokine release after stimulation of human whole blood by lipopolysaccharide and zymosan A.
Hartman DA; Ochalski SJ; Carlson RP
Inflamm Res; 1995 Jul; 44(7):269-74. PubMed ID: 8564522
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation.
Sekut L; Yarnall D; Stimpson SA; Noel LS; Bateman-Fite R; Clark RL; Brackeen MF; Menius JA; Connolly KM
Clin Exp Immunol; 1995 Apr; 100(1):126-32. PubMed ID: 7697910
[TBL] [Abstract][Full Text] [Related]
4. Regulation of tumour necrosis factor production by adrenal hormones in vivo: insights into the antiinflammatory activity of rolipram.
Pettipher ER; Labasi JM; Salter ED; Stam EJ; Cheng JB; Griffiths RJ
Br J Pharmacol; 1996 Apr; 117(7):1530-4. PubMed ID: 8730750
[TBL] [Abstract][Full Text] [Related]
5. Acute inflammatory response in the mouse: exacerbation by immunoneutralization of lipocortin 1.
Perretti M; Ahluwalia A; Harris JG; Harris HJ; Wheller SK; Flower RJ
Br J Pharmacol; 1996 Mar; 117(6):1145-54. PubMed ID: 8882609
[TBL] [Abstract][Full Text] [Related]
6. Suppression of acute lung injury in mice by an inhibitor of phosphodiesterase type 4.
Miotla JM; Teixeira MM; Hellewell PG
Am J Respir Cell Mol Biol; 1998 Mar; 18(3):411-20. PubMed ID: 9490659
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory and analgesic effects of the phosphodiesterase 4 inhibitor rolipram in a rat model of arthritis.
Francischi JN; Yokoro CM; Poole S; Tafuri WL; Cunha FQ; Teixeira MM
Eur J Pharmacol; 2000 Jul; 399(2-3):243-9. PubMed ID: 10884526
[TBL] [Abstract][Full Text] [Related]
8. Metalloelastase (MMP-12) induced inflammatory response in mice airways: effects of dexamethasone, rolipram and marimastat.
Nénan S; Lagente V; Planquois JM; Hitier S; Berna P; Bertrand CP; Boichot E
Eur J Pharmacol; 2007 Mar; 559(1):75-81. PubMed ID: 17234180
[TBL] [Abstract][Full Text] [Related]
9. Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram.
Ross SE; Williams RO; Mason LJ; Mauri C; Marinova-Mutafchieva L; Malfait AM; Maini RN; Feldmann M
J Immunol; 1997 Dec; 159(12):6253-9. PubMed ID: 9550429
[TBL] [Abstract][Full Text] [Related]
10. Effects of rolipram on cyclic AMP levels in alveolar macrophages and lipopolysaccharide-induced inflammation in mouse lung.
Gonçalves de Moraes VL; Singer M; Vargaftig BB; Chignard M
Br J Pharmacol; 1998 Feb; 123(4):631-6. PubMed ID: 9517381
[TBL] [Abstract][Full Text] [Related]
11. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
Seldon PM; Barnes PJ; Meja K; Giembycz MA
Mol Pharmacol; 1995 Oct; 48(4):747-57. PubMed ID: 7476903
[TBL] [Abstract][Full Text] [Related]
12. The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis.
Navikas V; Matusevicius D; Söderström M; Pirskanen R; Fredrikson S; Link H
Clin Neuropharmacol; 1998; 21(4):236-44. PubMed ID: 9704165
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of neutrophil and monocyte recruitment by endogenous and exogenous lipocortin 1.
Getting SJ; Flower RJ; Perretti M
Br J Pharmacol; 1997 Mar; 120(6):1075-82. PubMed ID: 9134220
[TBL] [Abstract][Full Text] [Related]
14. Suppression of tumor necrosis factor-alpha production by interleukin-10 is enhanced by cAMP-elevating agents.
Siegmund B; Eigler A; Moeller J; Greten TF; Hartmann G; Endres S
Eur J Pharmacol; 1997 Feb; 321(2):231-9. PubMed ID: 9063693
[TBL] [Abstract][Full Text] [Related]
15. The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells.
Semmler J; Wachtel H; Endres S
Int J Immunopharmacol; 1993 Apr; 15(3):409-13. PubMed ID: 8505151
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide induces expression of tumour necrosis factor alpha in rat brain: inhibition by methylprednisolone and by rolipram.
Buttini M; Mir A; Appel K; Wiederhold KH; Limonta S; Gebicke-Haerter PJ; Boddeke HW
Br J Pharmacol; 1997 Dec; 122(7):1483-9. PubMed ID: 9421299
[TBL] [Abstract][Full Text] [Related]
17. Elastolytic activity and alveolar epithelial type-1 cell damage after chronic LPS inhalation: effects of dexamethasone and rolipram.
Johnson FJ; Reynolds LJ; Toward TJ
Toxicol Appl Pharmacol; 2005 Sep; 207(3):257-65. PubMed ID: 16129118
[TBL] [Abstract][Full Text] [Related]
18. Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages.
Kambayashi T; Jacob CO; Zhou D; Mazurek N; Fong M; Strassmann G
J Immunol; 1995 Nov; 155(10):4909-16. PubMed ID: 7594495
[TBL] [Abstract][Full Text] [Related]
19. Comparison of PDE 4 inhibitors, rolipram and SB 207499 (ariflo), in a rat model of pulmonary neutrophilia.
Spond J; Chapman R; Fine J; Jones H; Kreutner W; Kung TT; Minnicozzi M
Pulm Pharmacol Ther; 2001; 14(2):157-64. PubMed ID: 11273798
[TBL] [Abstract][Full Text] [Related]
20. Prevention by rolipram of concanavalin A-induced T-cell-dependent hepatitis in mice.
Xiang M; Zaccone P; Di Marco R; Magro G; Di Mauro M; Beltrami B; Meroni PL; Nicoletti F
Eur J Pharmacol; 1999 Feb; 367(2-3):399-404. PubMed ID: 10079016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
